abstract |
Disclosed is a method for identifying a cancer patient, such as a breast cancer patient, suitable for treatment with a CENPE inhibitor, such as GSK923295A. The method involved detecting the modulated expression of CENPE and one or more of a set of predictive biomarkers, or protein encoded thereof. |